Marten Visser

2PUBLICATIONS
29CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 06, 2025
Effective TIL Therapy for Patients with Checkpoint-Resistant Melanoma without Lymphodepleting Regimens Requires IFNα.

Els M E Verdegaal, Anique L C Verpoorte, Monique K van der Kooij

|Aug 04, 2023
Neoantigen Targetability in Progressive Advanced Melanoma.

Jitske van den Bulk, Els M E Verdegaal, Manon van der Ploeg

Pageof 1